> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Repackaging Propofol During Covid Guide Withdrawn
- URL: https://www.fdaweb.com/repackaging-propofol-during-covid-guide-withdrawn/
- Published: 2023-02-13T12:00:00.000Z
- Updated: 2026-09-14T18:15:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5153763

*Federal Register* notice: FDA is announcing the withdrawal of a guidance entitled “Temporary Policy on Repackaging or Combining Propofol Drug Products During the COVID–19 Public Health Emergency.” The document was issued in 4/2020 to communicate a temporary policy regarding the repackaging or combining of propofol drug products. The agency says the conditions that created the need for this policy have evolved and the policy is no longer needed. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-02-10/pdf/2023-02809.pdf?ref=fdaweb.com).